DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name ▼ | Gene Symbol | Gene ID | Gene Name | UniProt ID |
---|---|---|---|---|---|
C1306459 | Primary malignant neoplasm | PIK3CD | 5293 | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | O00329 |
C1306459 | Primary malignant neoplasm | ACSL5 | 51703 | acyl-CoA synthetase long chain family member 5 | Q9ULC5 |
C1306459 | Primary malignant neoplasm | ENPP3 | 5169 | ectonucleotide pyrophosphatase/phosphodiesterase 3 | O14638 |
C1306459 | Primary malignant neoplasm | PIK3C2G | 5288 | phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma | O75747 |
C1306459 | Primary malignant neoplasm | ISYNA1 | 51477 | inositol-3-phosphate synthase 1 | Q9NPH2 |
C1306459 | Primary malignant neoplasm | PIK3C3 | 5289 | phosphatidylinositol 3-kinase catalytic subunit type 3 | Q8NEB9 |
C1306459 | Primary malignant neoplasm | PIK3C2A | 5286 | phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha | O00443 |
C1306459 | Primary malignant neoplasm | PLCG1 | 5335 | phospholipase C gamma 1 | P19174 |
C1306459 | Primary malignant neoplasm | PLA2G2A | 5320 | phospholipase A2 group IIA | P14555 |
C1306459 | Primary malignant neoplasm | PI4K2A | 55361 | phosphatidylinositol 4-kinase type 2 alpha | Q9BTU6 |
C1306459 | Primary malignant neoplasm | ACSS2 | 55902 | acyl-CoA synthetase short chain family member 2 | Q9NR19 |
C1306459 | Primary malignant neoplasm | AGK | 55750 | acylglycerol kinase | Q53H12 |
C1306459 | Primary malignant neoplasm | CACNA2D3 | 55799 | calcium voltage-gated channel auxiliary subunit alpha2delta 3 | Q8IZS8 |
C1306459 | Primary malignant neoplasm | PLD2 | 5338 | phospholipase D2 | O14939 |
C1306459 | Primary malignant neoplasm | SRGN | 5552 | serglycin | P10124 |
C1306459 | Primary malignant neoplasm | SMPD3 | 55512 | sphingomyelin phosphodiesterase 3 | Q9NY59 |
C1306459 | Primary malignant neoplasm | NGLY1 | 55768 | N-glycanase 1 | Q96IV0 |
C1306459 | Primary malignant neoplasm | PRG2 | 5553 | proteoglycan 2, pro eosinophil major basic protein | P13727 |
C1306459 | Primary malignant neoplasm | PLCG2 | 5336 | phospholipase C gamma 2 | P16885 |
C1306459 | Primary malignant neoplasm | PRNP | 5621 | prion protein | P04156 |
C1306459 | Primary malignant neoplasm | SULF2 | 55959 | sulfatase 2 | Q8IWU5 |
C1306459 | Primary malignant neoplasm | CMAS | 55907 | cytidine monophosphate N-acetylneuraminic acid synthetase | Q8NFW8 |
C1306459 | Primary malignant neoplasm | CFC1 | 55997 | cripto, FRL-1, cryptic family 1 | P0CG37 |
C1306459 | Primary malignant neoplasm | SPHK2 | 56848 | sphingosine kinase 2 | Q9NRA0 |
C1306459 | Primary malignant neoplasm | PRPS2 | 5634 | phosphoribosyl pyrophosphate synthetase 2 | P11908 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024